An Economic Evaluation: Simulation of the Cost-Effectiveness and Cost-Utility of Universal Prevention Strategies Against Osteoporosis-Related Fractures

被引:25
|
作者
Nshimyumukiza, Leon [1 ]
Durand, Audrey [1 ,2 ]
Gagnon, Mathieu [1 ]
Douville, Xavier [1 ]
Morin, Suzanne [3 ]
Lindsay, Carmen [4 ]
Duplantie, Julie [1 ]
Gagne, Christian [2 ]
Jean, Sonia [5 ]
Giguere, Yves [4 ,6 ]
Dodin, Sylvie [4 ,7 ]
Rousseau, Francois [4 ,7 ]
Reinharz, Daniel [1 ,4 ]
机构
[1] Univ Laval, Dept Med Sociale & Prevent, Fac Med, Quebec City, PQ G1V 0A6, Canada
[2] Univ Laval, Fac Sci & Genie, Dept Genie Elect, Quebec City, PQ G1V 0A6, Canada
[3] McGill Univ, Fac Med, Dept Internal Med, Montreal, PQ, Canada
[4] Univ Laval, CRCHUQ, Fac Med, Quebec City, PQ G1V 0A6, Canada
[5] Inst Sante Publ Quebec INSPQ, Quebec City, PQ, Canada
[6] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Fac Med, Quebec City, PQ G1V 0A6, Canada
[7] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ G1V 0A6, Canada
关键词
OSTEOPOROSIS; SCREENING; COMPUTER SIMULATIONS; COST-EFFECTIVENESS; COST-UTILITY; PREVENTION; BONE FRACTURES; BONE-MINERAL DENSITY; CLINICAL-PRACTICE GUIDELINES; QUALITY-OF-LIFE; WOMEN; DIAGNOSIS; CARE; PREFERENCES; VALIDATION; MANAGEMENT; IMPACT;
D O I
10.1002/jbmr.1758
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings. (C) 2013 American Society for Bone and Mineral Research.
引用
收藏
页码:383 / 394
页数:12
相关论文
共 50 条
  • [21] Reviewing the literature of cost-effectiveness and cost-utility analysis in health
    Sancho, Leyla Gomes
    CADERNOS DE SAUDE PUBLICA, 2008, 24 (12): : 2735 - 2746
  • [22] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    Osteoporosis International, 2004, 15 : 862 - 871
  • [23] Cost-effectiveness analysis of biphosphonates and raloxifene for treatment of osteoporosis and prevention of fractures
    Lau, TC
    Lim, BP
    Li, SC
    VALUE IN HEALTH, 2005, 8 (03) : 408 - 408
  • [24] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [25] COST OF OSTEOPOROSIS-RELATED HIP FRACTURES IN A PRIVATE TERTIARY HOSPITAL
    Ho, A. J.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S122 - S122
  • [26] A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients
    Jansen, Femke
    van Zwieten, Valesca
    Coupe, Veerle M. H.
    Leemans, C. Rene
    Leeuw, Irma M. Verdonck-de
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2016, 3 (02) : 125 - 136
  • [27] Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy
    van Waart, Hanna
    van Dongen, Johanna M.
    van Harten, Wim H.
    Stuiver, Martijn M.
    Huijsmans, Rosalie
    Hellendoorn-van Vreeswijk, Jeannette A. J. H.
    Sonke, Gabe S.
    Aaronson, Neil K.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (06): : 893 - 904
  • [28] Analysis of cost-effectiveness and cost-utility for immunosuppressive protocols in renal transplantation
    Keown, P
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1140 - 1141
  • [29] Posttransplant Hepatocellular Carcinoma Surveillance A Cost-effectiveness and Cost-utility Analysis
    Hessheimer, Amelia J.
    Vargas-Martinez, Ana Magdalena
    Trapero-Bertran, Marta
    Navasa, Miquel
    Fondevila, Constantino
    ANNALS OF SURGERY, 2023, 277 (02) : E359 - E365
  • [30] Modelled cost-effectiveness and cost-utility analysis of various treatment strategies in polish osteoporotic postmenopausal women without previous vertebral fractures
    Orlewska, E
    Lis, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S46 - S46